Volatility
March 12, 2021 | Daily JAM, Volatility, WPM |
Before you get too excited by that headline, note that a 30% hike in the dividend at Wheaton Precious Metals (WPM) will bring the payout to just 13 cents for the first quarter of 2021. But that’s still, as my grandmother used to say, better than a poke in the eye with a sharp stick. At the least it’s a vote of confidence by the company’s board of directors that they see strong revenue and earnings growth in the year ahead. Wheaton Precious Metals doesn’t actually do any mining itself. Instead it purchases a stream of production from miners of precious metals and cobalt.
March 8, 2021 | Daily JAM, FXY, JD, Jubak Picks, VGIT, Volatility |
Let’s be clear. I don’t have any idea of when the current selling in technology and high-valuation growth momentum stocks will end. It does seem likely to me, even after the March 9 bounce, that the rotation into cyclicals, vaccine recovery stocks, and value stocks will continue for a while. From that perspective, I’m glad that I added Invesco KBWB Bank ETF (KBWB), Vulcan Materials (VMC), Caterpillar (CAT), MGM Resorts International (MGM) and Coca Cola (KO) to my Jubak Picks Portfolio since the middle of February. And that I added Dow (DOW) and Citigroup (C) to my Dividend Portfolio in Mid-December. (All those picks are in the black since my purchase date. You can check the online portfolios to see by how much.) But now that the NASDAQ Composite has dropped into an official correction–down 10% from its February 12 high–I’d like to be holding some more cash in case
March 2, 2021 | Daily JAM, INCY, Jubak Picks, Volatility |
Shares of biotech stock Incyte (INCY) have been down significantly in 2021. For the year to date, as of the close on March 2, the shares were down 8.45%. In the last month they’ve tumbled 12.42%. So what’s wrong? Pretty much nothing. With the individual stock anyway. What we’re watching is a lot of selling in the biotech sector as part of the recent sell-off on risk. And on substantial profit taking.
February 26, 2021 | CRM, CTVA, Daily JAM, ILMN, ISRG, Jubak Picks, PANW, Top 50 Stocks, VMW, Volatility, WST, You Might Have Missed |
On to Stage #2 in my Special Report: “Profit and Protect–What you need to know about stock market stages for 2021. And to my rules for the sells and hedges in Stage #2 for 2021: When you win, you lose. (I just posted sells for ILMN, CTVA, WST and VMW)
February 25, 2021 | AMAT, Daily JAM, Jubak Picks, Short Term, Volatility |
I’m very reluctant to go bottom fishing here–since I can’t tell where the bottom might be and the one-day losses are significant here. Tesla (TSLA), for example, was down 8.06% TODAY. That’s $59.80 dollars a share. Teladoc (TDOC) dropped 13.74% or $34.98 a share. Guessing wrong on a bottom could be very expensive here. But I am willing to try a few trades. Nothing fancy. Very short-term. But using stocks with very strong longer-term stories that make me feel good about the longer-term prospects for the stocks. And to believe that there are significant numbers of potential bargain hunters hiding in the bushes. So, for example, I’ve been trading in and out of the Call Options on Applied Materials (AMAT).
February 23, 2021 | Daily JAM, Dividend Income, Jubak Picks, Morning Briefing, Top 50 Stocks, Volatility |
Yesterday tech tumbled but utilities, commodities like copper and even gold, and many “vaccine recovery” plays gained. Today almost everything is down.
Which to me is a sign that this now 6-day downturn is getting closer to an end. Right now, as of 1:30 a.m. in New York the NASDAQ is off another 2.32%. The brings the drop from the mid-february high to 6%. A little more than half way to a 10% correction. I don’t think we’re at the bottom yet. But I am looking for growth stories–which is not the same as “momentum growth stocks”–where the selling has created an opportunity.
February 17, 2021 | Daily JAM, Millennial, Videos, Volatility |
I’m starting up my videos on JubakAM.com again–this time using YouTube as a platform. The eleventh YouTube video “Lessons from the Texas Winter Storm: How to Invest in the Energy Grid” went up today.
February 9, 2021 | Daily JAM, Dividend Income, IEF, Jubak Picks, Perfect Five-ETFs, VGIT, Volatility |
A year ago, the yield on the 10-year Treasury note stood at 1.59%. From that point yields fell, leading to big gains for Treasuries and other bonds. Yields were down to 0.73% as of the week of April 15, 2020. And then hit their low for 2020 during the week of August 2 at 0.55%. Since then the story for long Treasuries has been just the reverse. By October 4, the yields on 10-year Treasuries were back ump to 0.78%. 0.83% by November 1. 0.93% on December 6. And then 1.16% today February 9. The forecast right now is that yields for long Treasuries aren’t done climbing either.
February 4, 2021 | Daily JAM, Stock Alerts, Volatility, VXRT |
I thought there was a possibility that Vaxart (VXRT) would recover from yesterday’s 60% drop on data from the initial Phase 1 trials of its coronavirus-vaccine-in-a-pill candidate. Especially because the initial reaction over-emphasized, in my opinion, the negatives in that data. But I suspected that yesterday’s downward trend would continue for at least another day and therefore chose to sell Vaxart shares out of my Volatility Portfolio.
February 3, 2021 | Daily JAM, Stock Alerts, Volatility, VXRT |
As of 3:00 p.m. New York time today, February 3, shares of Vaxart (VXRT) were down 58.50% to $9.69 on news that although its coronavirus vaccine candidate triggered several immune responses, it did not produce the neutralizing antibodies that prevent sa virus from replicating. I will sell shares out of my Volatility Portfolio tomorrow
February 1, 2021 | Daily JAM, Volatility, VXRT |
Ok, I don’t want to see “the next GameStop under every rock.” But Vaxart (VXRT) deserves a look or two. (The stock is a member of my Volatility Portfolio where it’s up 5.27 as of the close on February 1 since I added it to the portfolio on July 22, 2020. I also own shares in my personal portfolio.) Here’s what I see with the shares of this company that is in clinical trials of a vaccine for the coronavirus. Vaxart’s vaccine is a pill and it’s the only vaccine pill under development. Shares of Vaxart are up (as of the February 1 close) 54.93% in the last week and 172.68% in the last month. They’ve added 216.46% in the last 3 months and are up 172.68% for 2021 to date as of the close on February 1. The shares moved up another 29.97% today to $15.57 a share.
December 29, 2020 | Daily JAM, Jubak Picks, LGF/A, PE, Short Term, Volatility, YPF |
Sell today if you’re looking to sell to generate tax losses for 2020. After today, December 29, you can still sell but the losses will count for the 2021 tax year.
